A detailed history of Franklin Street Advisors Inc transactions in Amgen Inc stock. As of the latest transaction made, Franklin Street Advisors Inc holds 57,423 shares of AMGN stock, worth $18.5 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares
57,423
Previous 51,910 10.62%
Holding current value
$18.5 Million
Previous $14.8 Million 21.57%
% of portfolio
1.28%
Previous 1.09%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 18, 2024

BUY
$262.75 - $319.31 $1.45 Million - $1.76 Million
5,513 Added 10.62%
57,423 $17.9 Million
Q1 2024

Apr 15, 2024

BUY
$268.87 - $324.56 $1.3 Million - $1.57 Million
4,826 Added 10.25%
51,910 $14.8 Million
Q4 2023

Jan 18, 2024

BUY
$255.7 - $288.46 $1.05 Million - $1.18 Million
4,101 Added 9.54%
47,084 $13.6 Million
Q3 2023

Oct 10, 2023

BUY
$218.65 - $271.46 $755,435 - $937,894
3,455 Added 8.74%
42,983 $11.6 Million
Q2 2023

Jul 13, 2023

BUY
$214.27 - $253.37 $298,263 - $352,691
1,392 Added 3.65%
39,528 $8.78 Million
Q1 2023

Apr 12, 2023

SELL
$225.79 - $275.2 $73,381 - $89,440
-325 Reduced 0.85%
38,136 $9.22 Million
Q4 2022

Feb 07, 2023

SELL
$229.03 - $291.01 $258,345 - $328,259
-1,128 Reduced 2.85%
38,461 $10.1 Million
Q3 2022

Oct 11, 2022

BUY
$224.46 - $253.15 $936,896 - $1.06 Million
4,174 Added 11.79%
39,589 $8.92 Million
Q2 2022

Jul 13, 2022

BUY
$230.71 - $256.74 $3.97 Million - $4.41 Million
17,196 Added 94.38%
35,415 $8.62 Million
Q1 2022

Apr 18, 2022

BUY
$219.27 - $242.57 $2.82 Million - $3.12 Million
12,844 Added 238.96%
18,219 $4.41 Million
Q4 2021

Jan 26, 2022

BUY
$198.88 - $227.6 $539,760 - $617,706
2,714 Added 101.99%
5,375 $1.21 Million
Q3 2021

Oct 22, 2021

BUY
$212.27 - $248.7 $2,334 - $2,735
11 Added 0.42%
2,661 $566,000
Q2 2021

Aug 05, 2021

SELL
$233.58 - $259.14 $11,679 - $12,957
-50 Reduced 1.85%
2,650 $646,000
Q1 2021

May 04, 2021

SELL
$221.91 - $258.6 $42,606 - $49,651
-192 Reduced 6.64%
2,700 $672,000
Q4 2020

Feb 01, 2021

SELL
$216.38 - $257.67 $5,842 - $6,957
-27 Reduced 0.92%
2,892 $665,000
Q3 2020

Oct 21, 2020

BUY
$234.65 - $260.95 $53,265 - $59,235
227 Added 8.43%
2,919 $742,000
Q2 2020

Aug 06, 2020

SELL
$197.81 - $242.74 $96,135 - $117,971
-486 Reduced 15.29%
2,692 $635,000
Q1 2020

Apr 16, 2020

SELL
$182.24 - $241.7 $33,532 - $44,472
-184 Reduced 5.47%
3,178 $644,000
Q4 2019

Feb 14, 2020

BUY
$189.21 - $243.2 $21,380 - $27,481
113 Added 3.48%
3,362 $810,000
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $28,902 - $34,630
-166 Reduced 4.86%
3,249 $629,000
Q2 2019

Aug 07, 2019

SELL
$166.7 - $195.41 $22,671 - $26,575
-136 Reduced 3.83%
3,415 $629,000
Q1 2019

May 14, 2019

BUY
$180.87 - $203.88 $153,739 - $173,298
850 Added 31.47%
3,551 $675,000
Q1 2018

Apr 11, 2018

SELL
$169.43 - $198.0 $17,281 - $20,196
-102 Reduced 3.64%
2,701 $460,000
Q4 2017

Jan 10, 2018

BUY
$168.79 - $188.59 $17,216 - $19,236
102 Added 3.78%
2,803 $487,000
Q3 2017

Oct 11, 2017

BUY
$167.29 - $191.0 $451,850 - $515,891
2,701
2,701 $504,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Franklin Street Advisors Inc Portfolio

Follow Franklin Street Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Street Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Franklin Street Advisors Inc with notifications on news.